Marketwatch adverum
Web10 apr. 2024 · Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular and rare diseases. About the company Risk Analysis Makes less than USD$1m in revenue ($0) Currently unprofitable and not forecast to become profitable over the next 3 years Does not have a meaningful market cap ($72M) WebMarket cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares …
Marketwatch adverum
Did you know?
WebAdverum Biotechnologies Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ADVM updated stock price target summary. WebAdverum Biotechnologies Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ADVM stock price.
Web29 mrt. 2024 · Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Identify stocks … WebAdverum Biotechnologies Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ADVM stock price.
Web26 mrt. 2024 · Adverum (ADVM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well Adverum (ADVM): Strong Industry, … Web10 apr. 2024 · Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration …
WebAdverum Biotechnologies Inc. ADVM (U.S.: Nasdaq) REAL TIME 12:00 PM EDT 03/17/23 $0.8452USD -0.0028 -0.33% Volume 183,316 65 Day Avg Vol 491,019 1 Day Range …
Web23 sep. 2024 · As at June 2024, Adverum Biotechnologies had cash of US$236m and no debt. Looking at the last year, the company burnt through US$130m. Therefore, from … 64學運Web26 jun. 2024 · Adverum Biotechnologies stock price target raised to $6 from $4 at Truist MarketWatch 07:19 AM ET Thursday, Jul 07, 2024 Adverum Biotechnologies upgraded … 64定性Web10 apr. 2024 · Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead … 64安居平五路Web3 apr. 2024 · Learn more about Adverum Biotechnologies's (ADVM) dividend history, ex-dividend date, and yield. Zacks.com Our Research, Your Success 64安卓Web24 mrt. 2024 · A high-level overview of Adverum Biotechnologies, Inc. (ADVM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … 64家ci醫院名單WebAdverum Biotechnologies (NASDAQ:ADVM) Shares Cross Above 50 Day Moving Average of $1.23. Defense World 15 hrs ago. 64封Web2 mrt. 2024 · A company's cash runway is calculated by dividing its cash hoard by its cash burn. In September 2024, Adverum Biotechnologies had US$203m in cash, and was … 64尺寸